Related Experiment Video
Updated: May 23, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Colorectal Cancer Treatment During Pregnancy
Kathryn L Green1, Rachel Hatch1
1From Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract:
Colorectal cancer (CRC) impacts about 1 in 13,000 pregnancies in the United States. Although chemotherapy is generally avoided in pregnant patients due to a concern for adverse effects to the fetus, there are situations where the benefits outweigh the potential risks. In this article, we discuss a unique patient case of a 36-year-old woman diagnosed with CRC while pregnant. She received chemotherapy during her second and third trimesters and delivered a healthy baby at 34 weeks. Specific information about oncologic therapies for colorectal cancer in the setting of pregnancy is discussed. Additionally, this article highlights considerations around CRC diagnosis and cancer treatment during pregnancy.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Radiological Investigation I: X-ray and CT
Drugs for Treatment of Ulcerative Colitis in IBD
Endoscopic Procedures II: Colonoscopy
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
